Quick survey to assess risk for disturbances in mental cognition

New tool helps detect delirium in hospital patients

 

San Francisco, Cal., USA (August 7, 2013) – UC San Francisco researchers have developed a two-minute assessment tool to help hospital staff predict a patient’s risk of delirium, a change in mental cognition characterized by severe confusion and disorientation that can prolong hospital stays. The condition, which occurs in as many as one in five hospitalized patients, tends to develop rapidly and can lead to higher death rates and increased health care costs. The new tool is designed to be simple, efficient and accurate in helping to assess and treat patients at risk of developing delirium, the scientists said. The tool also can be used to identify patients who might be most suitable for new targeted interventions to prevent delirium, the authors reported.

 

The study will be published online August 7, 2013 in the Journal of Hospital Medicine.

 

“It’s estimated that up to one third of hospital-acquired delirium cases could be prevented with appropriate interventions, but those interventions are resource-intense and can’t be applied to everyone,” said lead author Vanja C. Douglas, MD, an assistant professor of clinical neurology in the UCSF Department of Neurology and holder of the Sara & Evan Williams Foundation Endowed Neurohospitalist Chair.

 

“Our objective was to develop a tool to predict delirium using elements that could be assessed quickly in the fast-paced environment of a hospital,” Douglas said. “The new tool can be completed by a nurse in two minutes, and provides a clinically useful and practical alternative to existing delirium prediction models.”

 

Delirium, an often serious disturbance in a patient’s mental abilities, results in confused thinking and decreased awareness of one’s environment. The precise sequence of events that take place in the body and brain which results in delirium is not well understood, the researchers noted. It is believed that the combination of an aging brain and acute illness creates an imbalance of neurotransmitters that leads to the confusion and disorientation of delirium. Adding powerful medications like narcotics to the mix can compound the problem.

 

Established risk factors for delirium include:

 

  • Older age;
  • Preexisting cognitive dysfunction;
  • Dehydration;
  • Severe illness;
  • Vision and hearing impairment;
  • Electrolyte abnormalities;
  • Overmedication.

 

In the new UCSF study, some 374 patients took part — each was older than 50 and not delirious when admitted to the hospital. The patients were predominately white and lived at home.

 

The research was conducted during 2010 and 2011 at UCSF and the San Francisco Veterans Affairs Medical Center.

 

On admission, the patients underwent a structured interview involving questions related to their baseline cognitive function, residence, type of pain, visual and hearing abilities, among other factors. Each patient’s nurses rated them on a scale from “not ill” to near the point of death.

 

All the patients were assessed for changes in cognition for six days or until they were discharged.

 

The scientists devised a tool they termed “AWOL,” a mnemonic standing for age (A); unable to spell “world” backward (W); not fully oriented to place (O); and moderate to severe illness severity (L).

 

The researchers found that subjects with higher AWOL scores were more likely to become disoriented and develop delirium. They also found that conversely, those with low AWOL scores were at relatively low risk of developing delirium, meaning that the AWOL tool could stratify patients into high- and low-risk groups.

 

Once identified, patients at greater risk of delirium should be triaged to an inpatient unit specializing in delirium prevention, the researchers said.

 

The authors noted some study limitations: non-English speaking patients were excluded for logistical reasons as well as patients with profound aphasia or those in alcohol withdrawal when admitted.

 

The authors also pointed out that prior research on delirium has focused on patients over age 70 since old age is a known risk factor. But for their study, the authors said they included patients aged 50 or older “because hospital-acquired delirium still occurs in this age group.” Indeed, in the study, 8 percent of patients 50-69 years old became delirious.

 

“It is imperative to be able to recognize those patients admitted to the hospital with medical conditions who are at risk for delirium so that they can be the focus of targeted prevention and treatment,” said senior author S. Andrew Josephson, MD, director of the UCSF Neurohospitalist Program and holder of the Carmen Castro Franceschi and Gladyne K. Mitchell Neurohospitalist Distinguished Professorship.

 

 

Co-authors from UCSF are Christine S. Hessler, MD; Gurpreet Dhaliwal, MD; John P. Betjemann, MD; Keiko A. Fukada, BA; Lama R. Alameddine, MA; Rachael Lucatorto, MD; and S. Claiborne Johnson, MD, PhD.

 

The research was supported by the Ruth E. Raskin Fund and a UCSF Dean’s Research Scholarship. These funding agencies had no role in the design and conduct of the study.

 

UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care.

 


 

University of California – San Francisco, 07.08.2013 (tB).

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…